These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23665110)

  • 1. Peripheral antinociceptive efficacy and potency of a novel opioid compound 14-O-MeM6SU in comparison to known peptide and non-peptide opioid agonists in a rat model of inflammatory pain.
    Khalefa BI; Mousa SA; Shaqura M; Lackó E; Hosztafi S; Riba P; Schäfer M; Ferdinandy P; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2013 Aug; 713(1-3):54-7. PubMed ID: 23665110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.
    Balogh M; Zádori ZS; Lázár B; Karádi D; László S; Mousa SA; Hosztafi S; Zádor F; Riba P; Schäfer M; Fürst S; Al-Khrasani M
    Neurochem Res; 2018 Jun; 43(6):1250-1257. PubMed ID: 29725918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
    Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M
    Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Morphine Analogs Produce Peripheral Antinociception within a Certain Dose Range of Their Systemic Administration.
    Lackó E; Riba P; Giricz Z; Váradi A; Cornic L; Balogh M; Király K; Csekő K; Mousa SA; Hosztafi S; Schäfer M; Zádori ZS; Helyes Z; Ferdinandy P; Fürst S; Al-Khrasani M
    J Pharmacol Exp Ther; 2016 Oct; 359(1):171-81. PubMed ID: 27435180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new potent analgesic agent with reduced liability to produce morphine tolerance.
    Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M
    Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
    Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
    Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
    Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
    Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
    J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-
    Zádor F; Mohammadzadeh A; Balogh M; Zádori ZS; Király K; Barsi S; Galambos AR; László SB; Hutka B; Váradi A; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32192229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
    Al-Khrasani M; Lackó E; Riba P; Király K; Sobor M; Timár J; Mousa S; Schäfer M; Fürst S
    Brain Res Bull; 2012 Feb; 87(2-3):238-43. PubMed ID: 22079588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
    Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
    Hua S; Cabot PJ
    Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the antinociceptive and temperature responses to morphine and fentanyl derivatives in rats.
    Savić Vujović KR; Vučković S; Srebro D; Ivanović M; Došen-Mićović L; Vučetić Č; Džoljić E; Prostran M
    Arch Pharm Res; 2013 Apr; 36(4):501-8. PubMed ID: 23440583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.
    Zádor F; Balogh M; Váradi A; Zádori ZS; Király K; Szűcs E; Varga B; Lázár B; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
    Eur J Pharmacol; 2017 Nov; 814():264-273. PubMed ID: 28864212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats.
    Balogh M; Zádor F; Zádori ZS; Shaqura M; Király K; Mohammadzadeh A; Varga B; Lázár B; Mousa SA; Hosztafi S; Riba P; Benyhe S; Gyires K; Schäfer M; Fürst S; Al-Khrasani M
    Front Pharmacol; 2019; 10():347. PubMed ID: 31024314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
    Iwaszkiewicz KS; Hua S
    Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
    Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
    Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration.
    Craft RM; Henley SR; Haaseth RC; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1535-42. PubMed ID: 8531126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.